Recent Activity

Loading...

SCPH

scPharmaceuticals, Inc. · NASDAQ

Performance

-1.25%

1W

+1.71%

1M

-17.25%

3M

-5.38%

6M

-24.24%

YTD

-57.85%

1Y

Profile

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Technical Analysis of SCPH 2024-05-10

Overview:

In analyzing the technical indicators for SCPH over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

...
See more ...

Recent News & Updates